Abstract
The perpetually evolving antimicrobial resistance (AMR) of C. difficile is an important contributor to its epidemiology and is a grave concern to global public health. This exacerbates the challenge of treating the infections caused by this multidrug-resistant causative organism of potentially life-threatening diarrhea.
Funding Information
  • HHS | National Institutes of Health (R01-AI132711)
  • HHS | National Institutes of Health (R01-AI149852)
  • HHS | National Institutes of Health (R21-AI159745)

This publication has 23 references indexed in Scilit: